These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of CHROMagar Bentz ML; Le N; Min B; Nunnally NS; Sullivan V; Tran M; Lockhart SR; Litvintseva A; Berkow EL; Sexton DJ Microbiol Spectr; 2024 Apr; 12(4):e0356423. PubMed ID: 38364098 [TBL] [Abstract][Full Text] [Related]
3. A lateral flow immunoassay for the rapid identification of Chalin A; Arvor A; Hervault AS; Plaisance M; Niol L; Simon S; Volland H Front Microbiol; 2024; 15():1439273. PubMed ID: 39021636 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Eazyplex® LAMP test for fast Candida auris direct detection of colonized patients. Hernández Felices FJ; Tormo Palop N; Salvador García C; Mulet Bayona JV; Guna Serrano MR; Gimeno Cardona C Mycoses; 2024 Jan; 67(1):e13665. PubMed ID: 37860835 [TBL] [Abstract][Full Text] [Related]
5. The Emergence of Wong SC; Chau PH; Chen H; So SY; Chiu KH; Chen JH; Li X; Chui CS; Yuen KY; Cheng VC Infect Drug Resist; 2024; 17():1419-1429. PubMed ID: 38623528 [TBL] [Abstract][Full Text] [Related]
6. Identification of Candida glabrata by a 30-second trehalase test. Freydière AM; Parant F; Noel-Baron F; Crepy M; Treny A; Raberin H; Davidson A; Odds FC J Clin Microbiol; 2002 Oct; 40(10):3602-5. PubMed ID: 12354852 [TBL] [Abstract][Full Text] [Related]
9. Current knowledge and practice of Candida auris screening in France: A nationwide survey from the French Society of Medical Mycology (SFMM). Guitard J; Bellanger AP; Dorin J; Cassaing S; Capitaine A; Gabriel F; Nicolas M; Coron N; Penn P; Moniot M; Quinio D; Ranque S; Sasso M; Lepape P; Dannaoui E; Brun S; Lacroix C; Cornu M; Debourgogne A; Durieux MF; Laurent G; Bru V; Bourgeois N; Brunet K; Chouaki T; Huguenin A; Hasseine L; Maubon D; Gangneux JP; Desbois-Nogard N; Houze S; Dalle F; Bougnoux ME; Alanio A; Costa D; Botterel F; Hennequin C J Mycol Med; 2024 Sep; 34(3):101490. PubMed ID: 38852225 [TBL] [Abstract][Full Text] [Related]
10. Lower (1,3)-β-D-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains: author's response. Mikulska M; Ullah N; Magnasco L; Codda G; Marchese A; Bassetti M Clin Microbiol Infect; 2024 Jun; ():. PubMed ID: 38851423 [No Abstract] [Full Text] [Related]
11. Verification, Analytical Sensitivity, Cost-effectiveness, and Comparison of 4 Komorowski AS; Aftanas P; Porter V; Katz K; Kozak RA; Li XX Open Forum Infect Dis; 2024 Jun; 11(6):ofae017. PubMed ID: 38887488 [TBL] [Abstract][Full Text] [Related]
12. Re: lower (1,3)-beta-D-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains by Mikulska et al. Adelman MW; Tran TT; Shukla B Clin Microbiol Infect; 2024 May; ():. PubMed ID: 38782258 [No Abstract] [Full Text] [Related]
13. Usefulness of Chromogenic Media with Fluconazole Supplementation for Presumptive Identification of Ruiz-Gaitán A; Sigona-Giangreco I; Pérez-Royo JM; Garcia-Bustos V; García-Hita M; Valentín-Gómez E; Almaraz SG; de Groot PWJ; Pemán J Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673041 [TBL] [Abstract][Full Text] [Related]
14. Utility of CHROMagar™ Candida Plus for presumptive identification of Candida auris from surveillance samples. Marathe A; Zhu Y; Chaturvedi V; Chaturvedi S Mycopathologia; 2022 Dec; 187(5-6):527-534. PubMed ID: 36355325 [TBL] [Abstract][Full Text] [Related]
15. Colonized patients by de Melo CC; de Sousa BR; da Costa GL; Oliveira MME; de Lima-Neto RG Front Cell Infect Microbiol; 2023; 13():1033707. PubMed ID: 36756619 [TBL] [Abstract][Full Text] [Related]
16. Spectrum and management of rare Ahmad S; Asadzadeh M; Al-Sweih N; Khan Z Ther Adv Infect Dis; 2024; 11():20499361241263733. PubMed ID: 39070702 [TBL] [Abstract][Full Text] [Related]
17. The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European Perspective. Arendrup MC; Armstrong-James D; Borman AM; Denning DW; Fisher MC; Gorton R; Maertens J; Martin-Loeches I; Mehra V; Mercier T; Price J; Rautemaa-Richardson R; Wake R; Andrews N; White PL Open Forum Infect Dis; 2024 Jul; 11(7):ofae372. PubMed ID: 39045012 [TBL] [Abstract][Full Text] [Related]
18. Unveiling the Hungarian landscape of laboratory and clinical management capacities for invasive fungal infections: navigating the frontlines against fungal menaces. Kovács R; Majoros L; Stemler J; Cornely OA; Salmanton-García J Ther Adv Infect Dis; 2023; 10():20499361231219315. PubMed ID: 38116297 [TBL] [Abstract][Full Text] [Related]
19. Outbreaks of Fungal Infections in Hospitals: Epidemiology, Detection, and Management. Douglas AP; Stewart AG; Halliday CL; Chen SC J Fungi (Basel); 2023 Oct; 9(11):. PubMed ID: 37998865 [TBL] [Abstract][Full Text] [Related]
20. The impact of increasing non-albicans Candida trends on diagnostics in immunocompromised patients. Abdel-Hamid RM; El-Mahallawy HA; Abdelfattah NE; Wassef MA Braz J Microbiol; 2023 Dec; 54(4):2879-2892. PubMed ID: 37936026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]